Variant report
Variant | nsv520495 |
---|---|
Chromosome Location | chr8:20942928-20944251 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:20940533..20944455-chr8:21040696..21044387,3 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150460867 | chr8:20943202-20943203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573564142 | chr8:20943206-20943207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190833566 | chr8:20943257-20943258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540952668 | chr8:20943306-20943307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552871636 | chr8:20943388-20943389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111256742 | chr8:20943392-20943393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180982864 | chr8:20943398-20943399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185970871 | chr8:20943406-20943407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138501733 | chr8:20943441-20943442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570565088 | chr8:20943508-20943509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191240816 | chr8:20943511-20943512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528473031 | chr8:20943513-20943514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114096867 | chr8:20943557-20943558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566908580 | chr8:20943581-20943582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571987983 | chr8:20943585-20943586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs111384626 | chr8:20943594-20943595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374943941 | chr8:20943658-20943659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558517581 | chr8:20943668-20943669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569422628 | chr8:20943669-20943670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536778018 | chr8:20943726-20943727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377349278 | chr8:20943746-20943747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555416150 | chr8:20943758-20943759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370696571 | chr8:20943759-20943760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73668149 | chr8:20943837-20943838 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs373851563 | chr8:20943861-20943862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552511317 | chr8:20943905-20943906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577517537 | chr8:20943913-20943914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34882429 | chr8:20943916-20943917 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs556918866 | chr8:20943966-20943967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372003553 | chr8:20943983-20943984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575381380 | chr8:20943992-20943993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138017203 | chr8:20943999-20944000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376971177 | chr8:20944000-20944001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140125208 | chr8:20944009-20944010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34104131 | chr8:20944016-20944017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71222179 | chr8:20944017-20944018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114737038 | chr8:20944065-20944066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183101356 | chr8:20944072-20944073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537582082 | chr8:20944126-20944127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528565394 | chr8:20944129-20944130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35190001 | chr8:20944164-20944165 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs565233547 | chr8:20944185-20944186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140668778 | chr8:20944249-20944250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6985275 | chr8:20944251-20944252 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20943200-20943800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
2 | chr8:20943400-20943800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
3 | chr8:20943400-20945000 | Enhancers | Psoas Muscle | Psoas |
4 | chr8:20943600-20944000 | Enhancers | Pancreas | Pancrea |